KAI-9531 Clinical Trials (2026): 5 Studies for Obesity & Healthy Volunteers
Hipa.ai Research · Source: ClinicalTrials.gov / AACT
Synced daily from ClinicalTrials.gov via AACT. Last sync: .
5 KAI-9531 clinical trials are catalogued on Hipa.ai from the AACT mirror of ClinicalTrials.gov, spanning 3 indications (including Obesity & Healthy Volunteers) and 5,001 total planned enrollment. 3 Phase 3 KAI-9531 trials and 1 Phase 2 are listed. 4 KAI-9531 clinical trials are actively recruiting at 81 U.S. sites across 25 states. Most recent activity: NCT07284901 (Apr 2028).
Where to Participate: All KAI-9531 Trial Sites in the U.S. (81 sites across 25 states)
Every actively recruiting KAI-9531trial site, sorted by state then city. Each row links to the trial detail page (eligibility, contacts, full study record). Sites no longer enrolling at the location level are excluded. ClinicalTrials.gov / AACT does not provide street-level addresses; the map link uses the facility's geocoded coordinates where available.
| State | Facility | City | Trial | Map |
|---|---|---|---|---|
| AL | Kailera Clinical Site | Anniston36207 | NCT07284875 | Map |
| AL | Kailera Clinical Site | Birmingham35294 | NCT07284875 | Map |
| AL | Kailera Clinical Site | Cullman35055 | NCT07284875 | Map |
| AL | Kailera Clinical Site | Cullman35055 | NCT07284901 | Map |
| AZ | Kailera Clinical Site | Glendale85308 | NCT07284979 | Map |
| AZ | Kailera Clinical Site | Phoenix85012 | NCT07284901 | Map |
| AZ | Kailera Clinical Site | Phoenix85012 | NCT07284979 | Map |
| AZ | Kailera Clinical Site | Sun City85351 | NCT07284875 | Map |
| AZ | Kailera Clinical Site | Sun City85351 | NCT07284901 | Map |
| AR | Kailera Clinical Site | Little Rock72205 | NCT07284901 | Map |
| AR | Kailera Clinical Site | Little Rock72205 | NCT07284979 | Map |
| CA | Kailera Clinical Site | Escondido92025 | NCT07284875 | Map |
| CA | Kailera Clinical Site | Escondido92025 | NCT07284901 | Map |
| CA | Kailera Clinical Site | Northridge91325 | NCT07284901 | Map |
| CA | Kailera Clinical Site | Northridge91325 | NCT07284979 | Map |
| CA | Kailera Clinical Site | Oceanside92058 | NCT07284901 | Map |
| CA | Kailera Clinical Site | Oceanside92058 | NCT07284979 | Map |
| CA | Kailera Clinical Site | Toluca Lake91602 | NCT07284875 | Map |
| CA | Kailera Clinical Site | Toluca Lake91602 | NCT07284901 | Map |
| CO | Kailera Clinical Site | Aurora80012 | NCT07284875 | Map |
| CT | Kailera Clinical Site | Bridgeport06606 | NCT07284875 | Map |
| CT | Kailera Clinical Site | Hamden06517 | NCT07284979 | Map |
| CT | Kailera Clinical Site | Stamford06905 | NCT07284901 | Map |
| CT | Kailera Clinical Site | Stamford06905 | NCT07284979 | Map |
| FL | Kailera Clinical Site | Jupiter33458 | NCT07284875 | Map |
| FL | Kailera Clinical Site | Jupiter33458 | NCT07284901 | Map |
| FL | Kailera Clinical Site | Orange City32763 | NCT07284901 | Map |
| FL | Kailera Clinical Site | Orange City32763 | NCT07284979 | Map |
| GA | Kailera Clinical Site | Albany31707 | NCT07284979 | Map |
| GA | Kailera Clinical Site | Lilburn30047 | NCT07284875 | Map |
| GA | Kailera Clinical Site | Lilburn30047 | NCT07284901 | Map |
| IL | Kailera Clinical Site | Chicago60640 | NCT07284979 | Map |
| IL | Kailera Clinical Site | Skokie60077 | NCT07284901 | Map |
| IL | Kailera Clinical Site | Skokie60077 | NCT07284979 | Map |
| IL | Kailera Clinical Site | Springfield62072 | NCT07284875 | Map |
| KS | Kailera Clinical Site | Newton67114 | NCT07284901 | Map |
| KS | Kailera Clinical Site | Newton67114 | NCT07284979 | Map |
| LA | Kailera Clinical Site | Shreveport71105 | NCT07284901 | Map |
| LA | Kailera Clinical Site | Shreveport71105 | NCT07284979 | Map |
| MD | Kailera Clinical Site | Columbia21045 | NCT07284875 | Map |
| MD | Kailera Clinical Site | Columbia21045 | NCT07284901 | Map |
| MI | Kailera Clinical Site | Farmington Hills48334 | NCT07284901 | Map |
| MI | Kailera Clinical Site | Farmington Hills48334 | NCT07284979 | Map |
| MT | Kailera Clinical Site | Missoula59804 | NCT07284901 | Map |
| MT | Kailera Clinical Site | Missoula59804 | NCT07284979 | Map |
| NE | Kailera Clinical Site | Lincoln68516 | NCT07284901 | Map |
| NV | Kailera Clinical Site | Las Vegas89119 | NCT07284875 | Map |
| NV | Kailera Clinical Site | Las Vegas89148 | NCT07284901 | Map |
| NV | Kailera Clinical Site | Las Vegas89148 | NCT07284979 | Map |
| NY | Kailera Clinical Site | Albany12203 | NCT07284901 | Map |
| NY | Kailera Clinical Site | Albany12203 | NCT07284979 | Map |
| NY | Kailera Clinical Site | Laurelton11413 | NCT07284901 | Map |
| NY | Kailera Clinical Site | Rochester14609 | NCT07284875 | Map |
| NC | Kailera Clinical Site | Greensboro27405 | NCT07284901 | Map |
| NC | Kailera Clinical Site | Morehead City28557 | NCT07284875 | Map |
| NC | Kailera Clinical Site | Morehead City28557 | NCT07284901 | Map |
| NC | Kailera Clinical Site | Morehead City28557 | NCT07284979 | Map |
| OK | Kailera Clinical Site | Chickasha73018 | NCT07284875 | Map |
| OK | Kailera Clinical Site | Chickasha73018 | NCT07284901 | Map |
| OK | Kailera Clinical Site | Norman73069 | NCT07284979 | Map |
| RI | Kailera Clinical Site | East Greenwich02818 | NCT07284979 | Map |
| SC | Kailera Clinical Site | Mauldin29662 | NCT07284875 | Map |
| SC | Kailera Clinical Site | North Charleston29405 | NCT07284979 | Map |
| SC | Kailera Clinical Site | Spartanburg29303 | NCT07284901 | Map |
| SC | Kailera Clinical Site | Spartanburg29303 | NCT07284979 | Map |
| TN | Kailera Clinical Site | Chattanooga37405 | NCT07284875 | Map |
| TX | Kailera Clinical Site | Amarillo79124 | NCT07284875 | Map |
| TX | Kailera Clinical Site | Amarillo79124 | NCT07284901 | Map |
| TX | Kailera Clinical Site | Brownsville78526 | NCT07284901 | Map |
| TX | Kailera Clinical Site | Brownsville78526 | NCT07284979 | Map |
| TX | Kailera Clinical Site | DeSoto75115 | NCT07284875 | Map |
| TX | Kailera Clinical Site | DeSoto75115 | NCT07284901 | Map |
| TX | Kailera Clinical Site | San Antonio78229 | NCT07284979 | Map |
| TX | Kailera Clinical Site | Tomball77375 | NCT07284875 | Map |
| TX | Kailera Clinical Site | Tomball77375 | NCT07284901 | Map |
| UT | Kailera Clinical Site | Salt Lake City84124 | NCT07284875 | Map |
| UT | Kailera Clinical Site | Salt Lake City84117 | NCT07284901 | Map |
| VA | Kailera Clinical Site | Danville24541 | NCT07284875 | Map |
| VA | Kailera Clinical Site | Manassas20110 | NCT07284979 | Map |
| VA | Kailera Clinical Site | Richmond23236 | NCT07284901 | Map |
| VA | Kailera Clinical Site | Richmond23236 | NCT07284979 | Map |
KAI-9531 clinical trials at a glance: phase × recruitment status
| Phase | recruiting | enrolling by invitation | completed | Total |
|---|---|---|---|---|
| P1 | 1 | 1 | ||
| P2 | 1 | 1 | ||
| P3 | 3 | 3 |
Recruiting KAI-9531 clinical trials (4)
Studies currently enrolling participants. Click any NCT ID to view the trial detail page (eligibility, sites, contacts).
| NCT ID | Title | Phase | Indication | Enrollment | Started |
|---|---|---|---|---|---|
| NCT07284901 | Efficacy and Safety of KAI-9531 Administered Once Weekly in Participants Living With Obesity or Overweight and Diabetes | P3 | Obesity With Diabetes | 1,700 | Jan 2026 |
| NCT07284979 | Efficacy and Safety of KAI-9531 Administered Once Weekly Compared With Semaglutide and Placebo in Participants Living With Obesity Who Do Not Have Diabetes | P3 | Obesity | 1,200 | Dec 2025 |
| NCT07284875 | Efficacy and Safety of KAI-9531 in Participants Living With Obesity or Overweight With Weight-Related Comorbidities Who Do Not Have Diabetes | P3 | Obesity | 1,800 | Dec 2025 |
| NCT07458269 | KAI-9531Efficacy and Safety of Ribupatide (KAI-9531) Administered Once Weekly in Participants Living With Obesity Who Do Not Have Diabetes | P2 | Obesity | 250 | Mar 2026 |
KAI-9531 clinical trials by indication
Obesity (3)
| NCT | Acronym | Phase | Status | Title |
|---|---|---|---|---|
| NCT07284979 | — | P3 | recruiting | Efficacy and Safety of KAI-9531 Administered Once Weekly Compared With Semaglutide and Placebo in Participants Living With Obesity Who Do Not Have Diabetes |
| NCT07284875 | — | P3 | recruiting | Efficacy and Safety of KAI-9531 in Participants Living With Obesity or Overweight With Weight-Related Comorbidities Who Do Not Have Diabetes |
| NCT07458269 | KAI-9531 | P2 | enrolling by invitation | Efficacy and Safety of Ribupatide (KAI-9531) Administered Once Weekly in Participants Living With Obesity Who Do Not Have Diabetes |
Obesity With Diabetes (1)
| NCT | Acronym | Phase | Status | Title |
|---|---|---|---|---|
| NCT07284901 | — | P3 | recruiting | Efficacy and Safety of KAI-9531 Administered Once Weekly in Participants Living With Obesity or Overweight and Diabetes |
Healthy Volunteers (1)
| NCT | Acronym | Phase | Status | Title |
|---|---|---|---|---|
| NCT07044401 | — | P1 | completed | A Single-dose Study to Investigate the Effect of Injection Site on KAI-9531 Relative Bioavailability in a Range of Body Mass Indices |
KAI-9531 pivotal trial highlights (Phase 2/3/4)
Phase-2/3/4 studies with named acronyms — the registration-grade trials most cited in label discussions and Wikipedia.
| Acronym | NCT | Phase | Status | Indication | Enrollment | PubMed |
|---|---|---|---|---|---|---|
| KAI-9531 | NCT07458269 | P2 | enrolling by invitation | Obesity | 250 | — |
All KAI-9531 trials (5)
Sorted by most recent activity (completion → start → posted date). Each row links to the trial detail page on Hipa.ai.
| NCT ID | Acronym | Title | Phase | Status | Enrollment | Sponsor | Started |
|---|---|---|---|---|---|---|---|
| NCT07284901 | Efficacy and Safety of KAI-9531 Administered Once Weekly in Participants Living With Obesity or Overweight and Diabetes | P3 | recruiting | 1,700 | Kailera | Jan 2026 | |
| NCT07284979 | Efficacy and Safety of KAI-9531 Administered Once Weekly Compared With Semaglutide and Placebo in Participants Living With Obesity Who Do Not Have Diabetes | P3 | recruiting | 1,200 | Kailera | Dec 2025 | |
| NCT07284875 | Efficacy and Safety of KAI-9531 in Participants Living With Obesity or Overweight With Weight-Related Comorbidities Who Do Not Have Diabetes | P3 | recruiting | 1,800 | Kailera | Dec 2025 | |
| NCT07458269 | KAI-9531 | Efficacy and Safety of Ribupatide (KAI-9531) Administered Once Weekly in Participants Living With Obesity Who Do Not Have Diabetes | P2 | enrolling by invitation | 250 | Kailera | Mar 2026 |
| NCT07044401 | A Single-dose Study to Investigate the Effect of Injection Site on KAI-9531 Relative Bioavailability in a Range of Body Mass Indices | P1 | completed | 51 | Kailera | Jul 2025 |
KAI-9531 clinical trials: frequently asked questions
- How many KAI-9531 clinical trials are there?
- 5 KAI-9531 clinical trials are catalogued on Hipa.ai, sourced from the AACT mirror of ClinicalTrials.gov. 4 are actively recruiting participants. 1 is marked completed.
- Are KAI-9531 clinical trials recruiting in 2026?
- Yes — 4 KAI-9531 trials are actively recruiting in 2026, with 81 U.S. sites across 25 states. See the recruiting trials and the per-state site list further down this page.
- What conditions is KAI-9531 being studied for?
- KAI-9531 is being studied for Obesity, Healthy Volunteers, Obesity With Diabetes, Overweight, Overweight With Diabetes. The trials are grouped by indication on this page.
- What phase is KAI-9531 in?
- KAI-9531 clinical trials span 3 Phase 3, 1 Phase 2, 1 Phase 1. The phase × status matrix at the top of this page breaks down counts by phase and recruitment status.
- Who sponsors KAI-9531 clinical trials?
- The lead sponsor across the most KAI-9531 trials is Kailera. Each trial row links to the full study detail page including sponsor information.
Sources and methodology
Trial inventory derived from the AACT mirror of ClinicalTrials.gov. Trials are filtered to those naming KAI-9531as an intervention. Phase, status, enrollment, sponsor, and dates are taken from the source `studies` table; primary indication is the first listed condition. Acronyms are extracted from each trial's brief title where present. PubMed links are populated for trials whose published primary outcomes have been indexed in our evidence cache.
Last refreshed .
Related pages on Hipa.ai: